Browse by all authors Browse By Author ID - Khanna, Rajiv

Browse Results (50 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set


  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999) Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 18: 10391-10396. 68   186
Tey, Siok-Keen, Goodrum, Felicia and Khanna, Rajiv (2010) CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138. Journal of General Virology, 91 : 2040-2048. 33   5 Cited 5 times in Scopus5
Crompton, Laura, Khan, Naeem, Khanna, Rajiv, Nayak, Laxman and Moss, Paul A. H. (2008) CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Blood, 111 4: 2053-2061. 22   17 Cited 18 times in Scopus18
White, C. A., Thomson, S. A., Cooper, L., van Endert, P. M., Tampe, R., Coupar, B., Qiu, L., Parsons, P. G., Moss, D. J. and Khanna, R. (2000) Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells. International Journal of Cancer, 75 4: 590-595. 18   19
Crough, T, Burrows, JM, Fazou, C, Walker, S, Davenport, MP and Khanna, R (2005) Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. European Journal of Immunology, 35 1: 139-149. 20   15 Cited 15 times in Scopus15
Sherritt, M., Bharadwaj, M., Khanna, R. and Moss, D. J. (2001) Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine, 19 27: 3769-3777. 91   15
Elkington, Rebecca, Shoukry, Naglaa H., Walker, Susan, Crough, Tania, Fazou, Chrysa, Kaur, Amitinder, Walker, Christopher M. and Khanna, Rajiv (2004) Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. European Journal of Immunology, 34 11: 3216-3226. 23   34 Cited 37 times in Scopus37
Misko, Ihor S., Cross, Simone M., Khanna, Rajiv, Elliott, Suzanne L., Schmidt, Christopher, Pye, Stephanie J. and Silins, Sharon L. (1999) Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America, 96 5: 2279-2284. 35   47
Kienzle, Norbert, Sculley, Tom B., Greco, Sonia and Khanna, Rajiv (1999) Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentation. Journal of Immunology, 162 12: 6963-6966. 34   12
Khanna, Rajiv, Silins, Sharon L., Weng, Zhiping, Gatchell, David, Burrows, Scott R. and Cooper, Leanne (1999) Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.. European Journal of Immunology, 29 5: 1587-1597. 19   14
Davis, J. E., Sherritt, M. A., Bharadwaj, M., Morrison, L. E., Elliott, S. L., Kear, L. M., Maddicks-Law, J., Kotsimbos, T., Gill, D., Malouf, M., Falk, M. C., Khanna, R. and Moss, D. J. (2004) Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. International Immunology, 16 7: 983-989. 62   10 Cited 10 times in Scopus10
Moss, D., Khanna, R., Sherritt, M., Elliott, S. L. and Burrows, S. R. (1999) Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.. Journal of acquired immune deficiency syndromes and human retrovirology, 21 : S80-S83. 26  
Burrows, Scott R., Khanna, Rajiv and Moss, Denis J. (1999) Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism. Blood, 93 3: 1020-1024. 27   13
Khanna, Rajiv, Sherritt, Martina and Burrows, Scott R. (1999) EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design. Journal of Immunology, 162 5: 3063-3069. 19   40 Cited 42 times in Scopus42
Smith, Corey, Elhassen, Diah, Gras, Stephanie, Wynn, Katherine K., Dasari, Vijayendra, Tellam, Judy, Tey, Siok-Keen, Rehan, Sweera, Liu, Yu Chih, Rossjohn, Jamie, Burrows, Scott R. and Khanna, Rajiv (2012) Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8 + T cells. Blood, 120 16: 3237-3245. 6   0 Cited 0 times in Scopus0
Tellam, J., Connolly, G., Green, K. J., Miles, J. J., Moss, D. J., Burrows, S. R. and Khanna, R. (2004) Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1. Journal of Experimental Medicine, 199 10: 1421-1431. 18   86 Cited 80 times in Scopus80
Gandhi, Maher K., Tellam, Judy T. and Khanna, Rajiv (2004) Epstein-Barr virus-associated Hodgkin's lymphoma. British Journal of Haematology, 125 3: 267-281. 29   52 Cited 62 times in Scopus62
Webb, N., Connolly, G., Tellman, J., Yap, A. S. and Khanna, R. (2008) Epstein-Barr Virus Associated modulation of Wnt Pathway is not dependent on latent membrane Protein-1. PLoS One, 3 9: e3254-e3254. 8   Cited 10 times in Scopus10
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006) Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 7: 2280-2289. 46   56 Cited 64 times in Scopus64
Duraiswamy, J., Burrows, J. M., Bharadwaj, M., Burrows, S. R., Cooper, L., Pimtanothai, N. and Khanna, R. (2003) Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. Journal of Virology, 77 13: 7401-7410. 21   29 Cited 28 times in Scopus28
Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M. and Khanna, R. (2003) Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology, 77 9: 5226-5240. 24   157 Cited 166 times in Scopus166
Gandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007) Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood, 110 4: 1326-1329. 69   43 Cited 52 times in Scopus52
Burrows, Scott R., Chen, Zhenjun, Archbold, Julia K., Tynan, Fleur E., Beddoe, Travis, Kjer-Nielsen, Lars, Miles, John J., Khanna, Rajiv, Moss, Denis J., Liu, Yu Chih, Gras, Stephanie, Kostenko, Lyudmila, Brennan, Rebekah M., Clements, Craig S., Brooks, Andrew G., Purcell, AnthonyW., McCluskey, James and Rossjohn, Jamie (2010) Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proceedings of the National Academy of Sciences of USA, 107 23: 10608-10613. 26   38 Cited 38 times in Scopus38
Khan, N, Hislop, A, Gudgeon, N, Cobbold, M, Khanna, R, Nayak, L, Rickinson, AB and Moss, PAH (2004) Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection. Journal of Immunology, 173 12: 7481-7489. 27   138 Cited 150 times in Scopus150
Gandhi, Maher K. and Khanna, Rajiv (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infectious Diseases, 4 12: 725-738. 23   183 Cited 209 times in Scopus209
Khanna, Rajiv and Diamond, Don J. (2006) Human cytomegalovirus vaccine: time to look for alternative options. Trends In Molecular Medicine, 12 1: 26-33. 12   39 Cited 40 times in Scopus40
Khanna, R., Moss, D. J. and Burrows, S. R. (1999) Immune control of EBV-associated diseases and its implication for vaccine design.. Immunological Reviews, 70 : 49-64. 14  
Crough, Tania and Khanna, Rajiv (2009) Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clinical Microbiology Reviews, 22 1: 76-98. 18   89 Cited 102 times in Scopus102
Khanna, R., Tellam, J., Duraiswamy, J. and Cooper, L. (2001) Immunotherapeutic strategies for EBV-associated malignancies. Trends in Molecular Medicine, 76 6: 270-276. 24   21
Wynn, K. K., Fulton, Z., Cooper, L., Silins, S., Gras, S., Archbold, J., Tynan, F., Miles, J. J., McCluskey, J., Burrows, S. R., Rossjohn, J. and Khanna, R. (2008) Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood, 111 8: 4283-4292. 29   19 Cited 24 times in Scopus24
Duraiswamy, Jaikumar, Bharadwaj, Mandvi, Tellam, Judy, Connolly, Geoff, Cooper, Leanne, Moss, Denis, Thomson, Scott, Yotnda, Patricia and Khanna, Rajiv (2004) Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine. Cancer Research, 64 4: 1483-1489. 34   49 Cited 54 times in Scopus54
Tellam, Judy, Fogg, Mark H., Rist, Michael, Connolly, Geoff, Tscharke, David, Webb, Natasha, Heslop, Lea, Wang, Fred and Khanna, Rajiv (2007) Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes. Journal of Experimental Medicine, 204 3: 525-532. 13   22 Cited 19 times in Scopus19
Wynn, Katherine K., Crough, Tania, Campbell, Scott, McNeil, Keith, Galbraith, Andrew, Moss, Denis J., Silins, Sharon L., Bell, Scott and Khanna, Rajiv (2009) Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients. Immunology and Cell Biology, 88 2: 125-135. 37   6 Cited 6 times in Scopus6
Gandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006) Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12 2: 460-464. 58   40 Cited 42 times in Scopus42
Khanna, R (2004) Predictive algorithms and T cell epitope mapping. Journal of Immunology, 173 5: 2895-2896. 16   0 Cited 1 times in Scopus1
Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M. and Khanna, R. (2003) Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype. Journal of Immunology, 171 3: 1407-1412. 16   30 Cited 27 times in Scopus27
Tellam, J, Connolly, G, Webb, N, Duraiswamy, J and Khanna, R (2003) Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity. Blood, 102 13: 4535-4540. 22   10 Cited 11 times in Scopus11
Sherritt, M. A., Bharadwaj, M., Burrows, J. M., Morrison, L. E., Elliott, S. L., Davis, J. E., Kear, L. M., Slaughter, R. E., Bell, S. C., Galbraith, A. J., Khanna, R. and Moss, D. J. (2003) Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy. Transplantation, 75 9: 1556-1560. 24   51 Cited 48 times in Scopus48
Pai, Saparna, O'Sullivan, Brendan J., Cooper, Leanne, Thomas, Ranjeny and Khanna, Rajiv (2002) RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells. Journal of Virology, 76 4: 1914-1921. 37   21 Cited 21 times in Scopus21
Burrows, J. M., Bromham, L., Woolfit, M., Piganeau, G., Tellam, J., Connolly, G., Webb, N., Poulsen, L., Cooper, L., Burrows, S. R., Moss, D. J., Haryana, S. M., Ng, M., Nicholls, J. M. and Khanna, R. (2004) Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from southeast Asia. Journal of Virology, 78 13: 7131-7137. 45   24 Cited 26 times in Scopus26
Crough, Tania, Fazou, Chrysa, Weiss, Julissa, Campbell, Scott, Davenport, Miles P., Bell, Scott C., Galbraith, Andrew, McNeil, Keith and Khanna, Rajiv (2007) Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8+ T-cell response. Journal of Virology, 81 20: 11538-11542. 69   18 Cited 17 times in Scopus17
Tellam, Judy, Sherritt, Martina, Thomson, Scott, Tellam, Ross, Moss, Denis J., Burrows, Scott R., Wiertz, Emmanuel and Khanna, Rajiv (2001) Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition. Journal of Biological Chemistry, 276 36: 33353-33360. 27   35
Burrows, S. R., Khanna, R., Silins, S. L. and Moss, D. (1999) The influence of anti-viral T cell responses on the alloreactive repertoire. Immunology Today, 20 5: 203-207. 21   43
Duraiswamy, Jaikumar, Sherritt, Martina, Thomson, Scott, Tellam, Judy, Cooper, Leanne, Connolly, Geoff, Bharadwaj, Mandvi and Khanna, Rajiv (2003) Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma. Blood, 101 8: 3150-3156. 66   64 Cited 67 times in Scopus67
Jurgens, Lisa A., Khanna, Rajiv, Weber, James and Orentas, Rimas J. (2006) Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: A novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma. Journal of Clinical Immunology, 26 1: 22-32. 12   11 Cited 11 times in Scopus11
Khanna, R., Moss, D. and Burrows, S. R. (1999) Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation.. Immunological Reviews, 170 : 49-64. 23   68
Zhong, Jie and Khanna, Rajiv (2007) Vaccine strategies against human cytomegalovirus infection. Expert Review of Anti-infective Therapy, 5 3: 449-459. 10   19 Cited 20 times in Scopus20
Moss, D. J., Khanna, R. and Bharadwaj, M. (2002) Will a vaccine to nasopharyngeal carcinoma retain orphan status?. Developments in Biologicals, 116 : 252-256. 30  
Moss, D. J., Khanna, R. and Bharadwaj, M. (2002). Will a vaccine to nasopharyngeal carcinoma retain orphan status?. In: , Developments in Biologicals. Orphan vaccines - Bridging the gap, Palm Cove, Queensland, (67-71). 25-29 Aug, 2001. 33  
Faulkner, Glenda C., Burrows, Scott R., Khanna, Rajiv, Moss, Denis J., Bird, A. Graham and Crawford, Dorothy H. (1999) X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus. Journal of Virology, 73 2: 1555-1564. 57   53